Corporate Reputation of Global Pharma Companies, 2021-2022: How do Pharma Companies Rank Two years into Covid
January 09, 2023 07:13 ET
|
Research and Markets
Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Global Edition" report has been added to ResearchAndMarkets.com's offering. ...
Corporate Reputation of Pharma Companies in 2021-2022: The Patient Perspective of 520 Cancer Patient Groups - Pfizer Ranked 1st, Roche/Genentech Ranked 2nd and Novartis was 3rd
January 05, 2023 05:53 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups" report has been added...
Corporate Reputation of the Pharma Companies 2021-2022 Based on 168 HIV/AIDS Patient Groups: AbbVie, BMS, Gilead Sciences, GSK, Janssen, Merck, Mylan, Roche/Genentech, Sandoz, Sanofi, Teva, ViiV
December 13, 2022 05:28 ET
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups" report has been...
The Corporate Reputation of Pharma in 2021-2022: The Views of 303 Rare-Disease Patient Groups on 32 Pharma Companies
December 09, 2022 07:18 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups" report has...
UK Patient's Perspective on the Corporate Reputation of Pharma, 2021-2022: The Views of 111 Patients Groups Two Years into COVID-19
December 09, 2022 07:13 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2021- The Patient Perspective - UK Edition - The Views of 111 Patient Groups" report has been added to ...
Survey of 1,500 Patient Groups on the Pharmaceutical Industry and ESG (Environmental, Social, and Governance) - Rankings of a Company's Effectiveness at Adopting and Communicating their ESG Agendas
December 09, 2022 07:08 ET
|
Research and Markets
Dublin, Dec. 09, 2022 (GLOBE NEWSWIRE) -- The "Pharma and ESG - The Patient Perspective - The Views of 1,500 Patient Groups" report has been added to ResearchAndMarkets.com's offering. This...
Global Bacteriophage Therapy Market Report 2022: Minimal Drug Toxicity, Self-Replication and Less Side Effects Among Benefits Fueling Adoption
November 28, 2022 08:43 ET
|
Research and Markets
Dublin, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The "Bacteriophage Therapy Market: Distribution by Therapeutic Area, Route of Administration, and Geography: Industry Trends and Global Forecasts,...
Global Counterfeit Drug Detection Devices Market Valuation to Exceed $1.3 Billion by 2026
September 07, 2022 06:43 ET
|
Research and Markets
Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Counterfeit Drug Detection Devices Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)" report has been...
Global AI in Pharma Market Report (2022 to 2031) - Featuring Novartis, Merck and GNS Healthcare Among Others
May 05, 2022 05:58 ET
|
Research and Markets
Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "AI In Pharma Global Market Report 2022, By Technology, Drug Type, Application" report has been added to ResearchAndMarkets.com's offering. This report...
Global Pharma, Biotech and Diagnostics Option and Evaluation Deals Report/Directory 2021
March 29, 2022 04:23 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to...